Earnings Call · Q2 FY2021·2021-08-04

Q2 21EPS +52.17%·Rev n/aQ1 21EPS +42.11%·Rev n/aQ4 20EPS -14.29%·Rev n/aQ3 20EPS +19.35%·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Eric Jaschke — Investor Relations

Serge Saxonov — Chief Executive Officer

Justin McAnear — Chief Financial Officer

−5.2%1d on move date−5.8% vs SPY3d−6.6%5d−12.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access